Jaguar Health Announces Closing of $6.0 Million Issuance and Sale of Designation-backed Note Related to Possible Tropical Disease Priority Review Voucher
This additional non-dilutive financing will support development program for lechlemer for the indication of the symptomatic relief of diarrhea and...